Economic Burden of Haemophilia from a Societal Perspective: A Scoping Review.

ABSTRACT:

Introduction

Haemophilia is a rare genetic bleeding disorder that leads to musculoskeletal complications. The high cost of haemophilia treatment necessitates a thorough evaluation of its economic burden. However, due to the difficulty of estimating direct non-medical, indirect, and intangible costs, studies often underestimate the actual economic burden of haemophilia. This scoping review aims to summarise economic studies in haemophilia conducted from a societal perspective.

Methods

A systematic search across eight scholarly databases, grey literature, and reference lists until the 5^th of July 2023 was conducted to identify relevant studies. The inclusion criteria encompassed full-text, English-language publications of economic analyses in congenital haemophilia

SUBMITTER: El-Sayed AA 

PROVIDER: S-EPMC11865401 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature